Implantable Infusion Pumps Market– Volume Forecast and Value Chain Analysis 2017-2025, Credence Research

Credence Research’s recent market research report on Implantable Infusion Pumps Market offers assessment of the prime trends expected to be witnessed in the market during the period from 2017 to 2025.

Browse Here For Full Report and Sample:

This report offers a detailed summary of the growth drivers, challenges, and future prospects governing the Platelet Rich Plasma (PRP) market, while presenting the current and projected market size over the upcoming years till 2025. The study also contains attractive investment proposition and competitive landscape assessment of the market, along with profiles of key competitors. This report presents a robust classification of the global Implantable Infusion Pumps Marketby key segments and regions while presenting the major prevalent trends observed respectively.

Major highlights of the study include:

  1. Synopsis of the global Platelet Rich Plasma (PRP) industry
  2. Classification of the Implantable Infusion Pumps Marketbased on their major segmentation and their forecast
  3. Analysis of market drivers, challenges and opportunities
  4. Competitive landscape analysis of the major market players
  5. Cross sectional market size and forecast of each regional market by individual segments for the period from 2016 to 2017 in terms of US$

Some of the major questions answered in this report are:

  1. Detailed structure of the global Platelet Rich Plasma (PRP) industry and market dynamics
  2. Market outlook for the forecast period from 2017 to 2025, historical and current trends, and emerging opportunities that the stakeholders need to consider
  3. The key market participants and their competitive position in 2017

Thus this report offers comprehensive qualitative and quantitative analysis of the global Implantable Infusion Pumps Marketthat will help the readers scale the prevalent market conditions, growth opportunities, and overall trends in the global Platelet Rich Plasma (PRP) market.

Browse Here For Full Report and Sample:

An infusion pump infuses fluids, medication or nutrients into a patient’s circulatory system. It is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used.

Infusion pumps can administer fluids in ways that would be impractically expensive or unreliable if performed manually by nursing staff. For example, they can administer as little as 0.1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient, up to maximum number per hour (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.

Because they can also produce quite high but controlled pressures, they can inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally (just within the surface of the central nervous system – a very popular local spinal anesthesia for childbirth). Source: Wikipedia

What is implantable infusion pump?

Consumers and health professionals are advised that Medtronic Australasia, in consultation with the TGA, has issued an updated hazard alert for the SynchroMed II implantable infusion pump regarding the known issue of over-infusion. The hazard alert provides updated information regarding contributing causes, occurrence rate and patient management recommendations.Investigation of this issue has not identified any single factor that causes this over-infusion, rather an interaction of several factors can increase the likelihood that a given pump will over-infuse.Some of these risk factors relate to clinical use conditions, such as use of non-indicated drug formulations, over-filling of the pump reservoir, operation of the pump with no fluid in the reservoir, catheter blockage and pump stops/motor stalls lasting more than 48 hours.

The updated estimated occurrence rate is less than 0.14% (approximately 1 in 700). Five occurrences have been reported in a prospective, long-term multi-centre registry study. In each of these cases over-infusion was associated with pumps being used to infuse drug formulations that were not indicated for use with this device.The ‘Information for consumers’ and ‘Information for all health professionals’ provided below remains appropriate.Patient management recommendations, provided in the ‘Information for surgeons and neurologists’ section in the previous 28 March 2014 statement below, have been updated to align with the information provided in the new hazard alert.Medtronic Australasia continues to provide quarterly reports to the TGA regarding the progress being made to comply with the requirements of a Consent Decree initiated in the United States. See the related TGA statement for further information. [Ref:]

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared for this task.

Latest Reports:

Melamine Polyphosphate Market:

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429
Ph: 1-800-361-8290

Related posts

Leave a Comment